The study of Lai et al. went on to show that TTF-1-high lung cancer cells of a lower intracellular cholesterol level are more sensitive to statins, raising the thesis that TTF-1 should be further investigated as a biomarker indicative of lung cancer vulnerability to statins. The gene discussed is TTF1; the disease is lung cancer.